Basic information Safety Supplier Related

2,4-DICHLORO-1,2,3,4-TETRAHYDRO-7-METHYLQUINAZOLINE

Basic information Safety Supplier Related

2,4-DICHLORO-1,2,3,4-TETRAHYDRO-7-METHYLQUINAZOLINE Basic information

Product Name:
2,4-DICHLORO-1,2,3,4-TETRAHYDRO-7-METHYLQUINAZOLINE
Synonyms:
  • 2,4-Dichloro-7-methylquinazoline
  • 2,4-DICHLORO-1,2,3,4-TETRAHYDRO-7-METHYLQUINAZOLINE
  • Quinazoline, 2,4-dichloro-7-methyl-
  • 7-Methyl-2,4-dichloroquinazoline
  • 2,4-dichloro-7-methyl-quinazoline - [D85942]
CAS:
25171-19-1
MF:
C9H6Cl2N2
MW:
213.06
Mol File:
25171-19-1.mol
More
Less

2,4-DICHLORO-1,2,3,4-TETRAHYDRO-7-METHYLQUINAZOLINE Chemical Properties

Boiling point:
292.4±33.0 °C(Predicted)
Density 
1.418±0.06 g/cm3(Predicted)
storage temp. 
under inert gas (nitrogen or Argon) at 2-8°C
pka
-0.15±0.30(Predicted)
Appearance
White to off-white Solid
More
Less

2,4-DICHLORO-1,2,3,4-TETRAHYDRO-7-METHYLQUINAZOLINE Usage And Synthesis

Synthesis

62484-15-5

25171-19-1

The general procedure for the synthesis of 2,4-dichloro-7-methylquinazoline from 7-methylquinazoline-2,4(1H,3H)-dione was as follows: in a reaction flask equipped with a reflux condenser and a calcium chloride drying tube, 7-methylquinazoline-2,4(1H,3H)-dione (233 g, 1.32 mol) and phosphoryl chloride (500 mL, 5.23 mol) were added, followed by 25 mL of N,N-dimethylaniline was added. When gas production stopped (after about 30 minutes), the reaction mixture was heated to reflux overnight. Upon completion of the reaction, the dark solution was cooled to room temperature and slowly poured into 4 L of ice water. The solution was slowly added to the ice-water mixture under vigorous stirring and ice was replenished at appropriate times to maintain the temperature below 5 °C. The cooled suspension was extracted with dichloromethane (2 x 1 L). The organic phases were combined, washed sequentially with water and saturated sodium chloride solution (0.5 L), dried over anhydrous sodium sulfate and filtered. The organic layer was filtered through a silica gel plug and the filtrate was collected. The filtrate was concentrated to half the original volume, 0.5 L of heptane was added to each portion of the concentrate and evaporation was continued until crystals began to precipitate. The mixture was cooled to 5 °C and the precipitated solids were collected by filtration to give two 2,4-dichloro-7-methylquinazolines: 123 g (44%) off-white solid and 79 g (28%) yellow solid.

References

[1] Bioorganic and Medicinal Chemistry Letters, 2012, vol. 22, # 1, p. 461 - 467
[2] Bioorganic and Medicinal Chemistry Letters, 2009, vol. 19, # 17, p. 4980 - 4983
[3] Patent: WO2006/28904, 2006, A1. Location in patent: Page/Page column 159-160
[4] Patent: US2008/167305, 2008, A1. Location in patent: Page/Page column 55
[5] Patent: WO2018/33082, 2018, A1. Location in patent: Paragraph 00404

2,4-DICHLORO-1,2,3,4-TETRAHYDRO-7-METHYLQUINAZOLINESupplier

Shangchem Co., Ltd.
Tel
+86-21-68182121
Shanghai Ennopharm Co., Ltd.
Tel
+86 (21) 6435-5022
Chiba Pharmaceutical Science and technology Co, Ltd.
Tel
0531-81313138 13066006660
Email
chibapharm@foxmail.com
Shanghai Topbiochem Technology Co., Ltd
Tel
+86-21-60341587
Email
sales@topbiochem.com
Shanghai Jian Chao Chemical Technology Co., Ltd.
Tel
150-2103-5486 18017383231
Email
983544897@qq.com